Agios Pharmaceuticals

Agios to Receive $1.1B Following FDA Approval of Vorasidenib
Contract Pharma
Wed, 08/7/24 - 11:26 am
Agios Pharmaceuticals
vorasidenib
Servier
glioma
Agios Blood Disorder Drug Scores Another Phase III Win
BioSpace
Mon, 06/3/24 - 10:47 pm
Agios Pharmaceuticals
Pyrukynd
clinical trials
transfusion-dependent alpha- or beta-thalassemia
With trial win for oral thalassemia drug, Agios charts broader path than gene therapy rivals
Fierce Pharma
Wed, 01/3/24 - 05:01 pm
Agios Pharmaceuticals
mitapivat
beta thalassemia
gene therapy
Agios and Alnylam sign agreement for siRNA candidate
Pharmaceutical Business Review
Fri, 08/4/23 - 12:09 pm
Agios Pharmaceuticals
Alnylam
siRNA
polycythemia vera
Agios Touts Encouraging Action From Sickle Cell Disease Study With Mitapivat
Yahoo/Benzinga
Mon, 06/26/23 - 08:45 pm
Agios Pharmaceuticals
clinical trials
sickle cell disase
mitapivat
How 2 biotechs survived 2022’s rocky market—and why their CEOs see success on the horizon
Fierce Biotech
Wed, 01/18/23 - 11:12 pm
Agios Pharmaceuticals
Cerevel Therapeutics
JPMHC 2023
layoffs
Agios sells cancer drug royalty, raising $132M to fund rare disease mission
MedCity News
Fri, 10/28/22 - 10:23 am
Agios Pharmaceuticals
Tibsovo
11 drugs granted FDA fast track designation in 2022
Beckers Hospital Review
Wed, 08/24/22 - 10:55 pm
FDA
fast track
Agios Pharmaceuticals
CTI BioPharma
Bristol Myers Squibb
Nobel Biocare
BioXcel Therapeutics
Mycovia Pharmaceuticals
Phathom Pharmaceuticals
Mitsubishi Tanabe Pharma
SIGA technologies
Alnylam Pharmaceuticals
Agios to cut jobs as it moves away from exploratory research
BioPharma Dive
Mon, 05/16/22 - 07:31 pm
Agios Pharmaceuticals
layoffs
R&D
FDA Approvals Roundup: Pyrukynd and Solosec
RAPS.org
Thu, 02/24/22 - 09:57 am
Agios Pharmaceuticals
Pyrukynds
FDA
Solosec
Lupin
Agios strategy shift pays off with FDA approval of first drug for rare anemia
MedCity News
Mon, 02/21/22 - 10:28 am
Agios Pharmaceuticals
FDA
pyruvate kinase deficiency
anemia
mitapivat
4 Biotechs That Were Winners at ASH
Motley Fool
Mon, 01/3/22 - 10:38 am
ASH2021
Bristol Myers Squibb
Agios Pharmaceuticals
Forma Therapeutics
Bluebird Bio
sickle cell disease
Multiple Myeloma
The "Rare Disease Company Coalition" Launches to Share the Unique Challenges and Promise of Rare Disease Therapy Development to Support Continued Progress and Patient Access
Yahoo/Businesswire
Thu, 05/13/21 - 12:04 pm
Rare Diseases
Rare Disease Company Coalition
drug development
drug discovery
Acceleron
Aeglea BioTherapeutics
Agios Pharmaceuticals
Alnylam
Harmony Biosciences
Orchard Therapeutics
Orphazyme
Sarepta Therapeutics
Taysha Gene Therapies
Ultragenyx
Agios readies FDA filing as anemia drug clears another phase 3
Fierce Biotech
Wed, 01/27/21 - 11:21 am
Agios Pharmaceuticals
mitapivat
pyruvate kinase deficiency
clinical trials
Agios, changing its identity, to sell cancer drug business to Servier
BioPharma Dive
Mon, 12/21/20 - 11:11 am
Agios Pharmaceuticals
cancer
M&A
Servier
Agios' anemia drug hits goal in phase 3, teeing up 2021 filing
Fierce Biotech
Tue, 12/1/20 - 10:55 am
Agios Pharmaceuticals
mitapivat
anemia
PK deficiency
Agios helps identify genes that allow cancer to escape the immune system
Fierce Biotech
Thu, 09/24/20 - 10:18 am
CRISPR
cancer
Agios Pharmaceuticals
immuno-oncology
Agios up as FDA gives Thermo Fisher glioma test breakthrough status
Pharmaforum
Tue, 06/16/20 - 10:35 am
Agios Pharmaceuticals
FDA
vorasidenib
brain cancer
glioma
The 20 most expensive pharmacy drugs in the U.S. in 2020, from fallen blockbusters to new orphan meds
Fierce Pharma
Fri, 02/14/20 - 05:11 pm
drug pricing
Amryt Pharma
Myalept
Agios Pharmaceuticals
Tibsovo
The Week Ahead In Biotech: Adcom Test For Agile; Pfizer, Merck Lead Earnings
Yahoo/Benzinga
Sun, 10/27/19 - 10:55 pm
Adamis Pharmaceuticals
Redhill Biopharma
Amag Pharmaceuticals
Arqule
Agile Therapeutics
Agios Pharmaceuticals
Deciphera
Mirati Therapeutics
Sutro BioPharma
Merck
Pfizer
Amgen
EXACT Sciences
Bristol-Myers Squibb
Celgene
Oyster Point Pharma

Pages